Correlation Between Pliant Therapeutics and CEL SCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and CEL SCI Corp, you can compare the effects of market volatilities on Pliant Therapeutics and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and CEL SCI.

Diversification Opportunities for Pliant Therapeutics and CEL SCI

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pliant and CEL is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and CEL SCI go up and down completely randomly.

Pair Corralation between Pliant Therapeutics and CEL SCI

Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 0.59 times more return on investment than CEL SCI. However, Pliant Therapeutics is 1.7 times less risky than CEL SCI. It trades about -0.02 of its potential returns per unit of risk. CEL SCI Corp is currently generating about -0.03 per unit of risk. If you would invest  2,267  in Pliant Therapeutics on September 2, 2024 and sell it today you would lose (887.00) from holding Pliant Therapeutics or give up 39.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pliant Therapeutics  vs.  CEL SCI Corp

 Performance 
       Timeline  
Pliant Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pliant Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
CEL SCI Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pliant Therapeutics and CEL SCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pliant Therapeutics and CEL SCI

The main advantage of trading using opposite Pliant Therapeutics and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.
The idea behind Pliant Therapeutics and CEL SCI Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.